These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 2447540)

  • 41. Screening for open neural tube defects.
    Krantz DA; Hallahan TW; Sherwin JE
    Clin Lab Med; 2010 Sep; 30(3):721-5. PubMed ID: 20638584
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Alpha-fetoprotein in the amniotic fluid in normal pregnancy].
    Brambati B; Dambrosio F; Mariani V; Bassi AS; Pietrogrande M
    Ann Ostet Ginecol Med Perinat; 1979; 100(5):341-9. PubMed ID: 95552
    [No Abstract]   [Full Text] [Related]  

  • 43. Sonography as a procedure complementary to alpha-fetoprotein testing for neural tube defects.
    Slotnick N; Filly RA; Callen PW; Golbus MS
    J Ultrasound Med; 1982 Oct; 1(8):319-22. PubMed ID: 6187932
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The sensitivity of ultrasound and serum alpha-fetoprotein in population-based antenatal screening for neural tube defects. South Australia 1986-1991.
    Chan A; Robertson EF; Haan EA; Ranieri E; Keane RJ
    Br J Obstet Gynaecol; 1995 May; 102(5):370-6. PubMed ID: 7542023
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Prenatal diagnosis of neural tube defects].
    Agosti S; Brambati B; Cucconi T; Mariani V
    Pediatr Med Chir; 1982; 4(1-2):71-7. PubMed ID: 6180415
    [No Abstract]   [Full Text] [Related]  

  • 46. Prenatal detection of neural tube defects: experience with alpha-fetoprotein assays of amniotic fluid.
    Milunsky A
    UCLA Forum Med Sci; 1978; 20():163-8. PubMed ID: 80857
    [No Abstract]   [Full Text] [Related]  

  • 47. Fetal oculocerebrorenal syndrome of Lowe associated with elevated maternal serum and amniotic fluid alpha-fetoprotein levels.
    Miller RC; Wolf EJ; Gould M; Macri CJ; Charnas LR
    Obstet Gynecol; 1994 Jul; 84(1):77-80. PubMed ID: 7516514
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Maternal serum alpha-fetoprotein screening: report of a Canadian pilot project.
    Doran TA; Valentine GH; Wong PY; Wielgosz G; Benzie RJ; Soltan HC; Jenner MR; Morland PA; Montgomery RJ; Allen LC
    CMAJ; 1987 Aug; 137(4):285-93. PubMed ID: 2440547
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Prenatal diagnosis of neural tube defects by determination of alpha-1-fetoprotein concentration in amniotic fluid and maternal serum].
    Jovanovic V; Rauskolb R; Fuhrmann W; Haas-Andela H; Bleyl H
    Arch Gynecol; 1979 Jul; 228(1-4):194-5. PubMed ID: 90480
    [No Abstract]   [Full Text] [Related]  

  • 50. [Prenatal diagnosis and prevention of neural tube defects].
    Notholt B; Karch D
    Z Geburtshilfe Perinatol; 1983; 187(6):259-63. PubMed ID: 6198810
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Alpha-fetoprotein.
    Drugan A; Dvorin E; Obrien JE; Johnson MP; Evans MI
    Curr Opin Obstet Gynecol; 1991 Apr; 3(2):230-4. PubMed ID: 1717020
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prenatal diagnosis of neural tube defects. III. A reevaluation of the alpha-fetoprotein assay.
    Kimball ME; Milunsky A; Alpert E
    Obstet Gynecol; 1977 May; 49(5):532-6. PubMed ID: 66652
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prenatal diagnosis of neural tube defects. IV. Maternal serum alpha-fetoprotein screening.
    Milunsky A; Alpert E; Neff RK; Frigoletto FD
    Obstet Gynecol; 1980 Jan; 55(1):60-6. PubMed ID: 6153240
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association of neural tube defects with omphalocele in chromosomally normal fetuses.
    Ardinger HH; Williamson RA; Grant S
    Am J Med Genet; 1987 May; 27(1):135-42. PubMed ID: 2440304
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The detection of neural tube closure defects by exfoliative cytology of amniotic fluid.
    Chapman PA; Blenkinsopp WK; Lewis BV
    Acta Cytol; 1981; 25(4):367-72. PubMed ID: 6169246
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Amniotic fluid test for the diagnosis of neural tube defects.
    Lituania M; Canini S; Cordone M; Lenzi A
    J Nucl Med Allied Sci; 1989; 33(3 Suppl):63-6. PubMed ID: 2480426
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Amniotic fluid alpha-fetoprotein and acetylcholinesterase in early genetic amniocentesis.
    Drugan A; Syner FN; Greb A; Evans MI
    Obstet Gynecol; 1988 Jul; 72(1):35-8. PubMed ID: 2454439
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Prenatal detection of open neural tube defects in a mass screening program by determination of alpha-fetoprotein concentration in maternal serum].
    Zwahr C; Körner H; Tinschert S; Horn A; Schulze M; Voigt M
    Zentralbl Gynakol; 1988; 110(3):158-67. PubMed ID: 2452529
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunochemical determination of amniotic fluid acetylcholinesterase in the antenatal diagnosis of open neural tube defects.
    Loft AG
    Dan Med Bull; 1995 Feb; 42(1):54-70. PubMed ID: 7729170
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neural tube defects: maternal serum screening and prenatal diagnosis.
    Crandall BF; Lebherz TB; Freihube R
    Pediatr Clin North Am; 1978 Aug; 25(3):619-29. PubMed ID: 80780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.